Wiener Privatklinik
Bookimedは鼠径ヘルニア手術価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで鼠径ヘルニア手術代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。鼠径ヘルニア手術で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。鼠径ヘルニア手術の旅路でお一人になることはありません。
Harald Rosen医師は低侵襲内視鏡手術を専門とし、ウィーン私立病院（Wiener Privatklinik）において複雑な消化器手術に数十年の専門的経験を持ちます。
Dr. Alexander M. Rokitansky is a pediatric and adolescent surgeon and a pioneer of minimally invasive correction of pectus excavatum. He oversaw the creation of the pediatric surgery department at University Hospital Vienna from 1992 to 1994. He then led Pediatric and Adolescent Surgery at Klinik Donaustadt for 27 years, from 1994 to 2021. He chaired the Society for Pediatric Surgery and Intensive Care. He also led the Ludwig Boltzmann Institute of Pediatric Surgery and served as President of the Austrian Pediatric Surgery Society.
He earned his doctorate at the University of Vienna in 1982. He has been Professor of Pediatric and Adolescent Surgery at SFU Vienna since 2017. He has been Chief Surgeon at Vienna Private Clinic since 2021. Honors include an honorary doctorate from Carol Davila University (2012), honorary membership of the Austrian Society of Pediatric Surgery (2023), and the Golden Badge of Honor of the City of Vienna (2023).
Dr. Martin Schindl is a senior consultant at the University Hospital of Surgery, Vienna General Hospital. He specializes in surgery of the pancreas, liver, gallbladder, and bile ducts. He also focuses on surgical cancer therapy. Dr. Schindl leads the surgical outpatient clinic for pancreatic and biliary diseases. He coordinates the interdisciplinary pancreatic cancer group at the Comprehensive Cancer Center Vienna.
He founded the ABCSG Pancreas Working Group. Dr. Schindl reviews articles for international surgical journals. He is a member of several national and international surgical societies. He also serves on the ethics committee of the Medical University of Vienna. Dr. Schindl has made important contributions to cancer therapy research and patient support programs.